Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's lead product candid...
Q1 2026
May 14, 2026
FY 2025
Mar 27, 2026
Q4 2025
Q3 2025
Nov 13, 2025
Q2 2025
Aug 7, 2025